Skip to content
★ Sign in to follow
GA

Gaurav Aggarwal

Board Director
Director
Sierra Oncology, Inc.Unicycive Therapeutics, Inc.Geron CorpOcera Therapeutics, Inc.Hyperion Therapeutics Inc
Total declarations
12
Companies
5
▲ Purchases (4 ops.)
€19.5M
▼ Sales (0 ops.)
—

Latest filing published 26 Aug 2025 for Unicycive Therapeutics, Inc..

Filing timeline

BuySale
Gaurav Aggarwal

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Gaurav Aggarwal: trading record in brief

This profile gathers the share dealings of Gaurav Aggarwal across 5 companies, led by Sierra Oncology, Inc., Unicycive Therapeutics, Inc. and Ocera Therapeutics, Inc. Between 31 July 2012 and 25 August 2025, the trades on record add up to 12 filings.

No open-market sale appears; the market trades are 4 purchases worth €19.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants.

In size, the median ticket on the buying side is €32k.

Most recently, on 26 August 2025, the filings show a transaction in Unicycive Therapeutics, Inc. The clock since the last published purchase (31 January 2022) now reads 1,743 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Gaurav Aggarwal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations